Viewing Study NCT04091204

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-06-25 @ 1:35 AM
Study NCT ID: NCT04091204
Status: UNKNOWN
Last Update Posted: 2023-03-24
First Post: 2019-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study
Sponsor: National Cancer Institute, Naples
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None wild-type BRCA 1 and 2 View
None platinum sensitive View
None recurrent ovarian cancer View
None olaparib View
None maintenance treatment View